Reference
Ho H-E, et al. 130 Biologic Use and Outcomes in CVID Enteropathy. Clinical Immunology 262 (Suppl.): May 2024. Available from: URL: https://dx.doi.org/10.1016/j.clim.2024.110072 [abstract]
Rights and permissions
About this article
Cite this article
Vedolizumab. Reactions Weekly 2007, 330 (2024). https://doi.org/10.1007/s40278-024-58890-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-58890-3